Science Corporation Secures $400 Million Series D Funding at $3.5 Billion Valuation
Science Corporation, a medical technology startup founded by former Neuralink president Max Hodak, has raised $400 million in a Series D funding round. The new capital brings the company's valuation to approximately $3.5 billion. Investors participating in this round include Khosla Ventures, Tenet Healthcare, Y Combinator, and others. The company is currently focused on its first product, PRIMA, a wearable and implantable chip designed to restore vision for patients with age-related macular degeneration. While already available in Germany, the startup plans to use the funding to pursue FDA approval via the Humanitarian Device Exemption to enter the United States market. Beyond vision restoration, Science Corporation is developing long-term bio-hybrid sensors composed of cultured neurons and silicon. In collaboration with Yale neurosurgery professor Murat Günel, the company is designing human trials that could eventually target treatments for Parkinson’s disease and other neurological injuries.

Tickers: $THC
Topics: Biotechnology Brain technology Medical devices Series D funding Startup valuation
Read the full article at TechCrunch
Part of the story Isomorphic Labs Secures $5 Billion in Series C Funding to Advance AI Drug Discovery (4 articles)